Orthogon Therapeutics Closes Oversubscribed $5.2M Financing to Advance First Oral Therapy for BK Polyomavirus
CANTON, Mass. - Tuesday, 10. December 2024 AETOSWire Orthogon’s small molecule therapeutics redefine treatment possibilities for BK virus...